SLC9A1 and breast carcinoma: However, patients with high SLC9A1 mRNA expression suffering from luminal A breast cancer showed significantly improved survival (hazard ratio 0.552) compared to patients with low SLC9A1 mRNA expression (Figure 9D), which is consistent with our observation of reduced lymph node metastasis among patients with high NHE1 protein expression (Figure 8G).